Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis

HIGHLIGHTS

  • who: Taylor T. Teague from the Department of Pulmonary and Critical Care Medicine, Mayo Clinic, First Street SW, Rochester, MN, USA have published the Article: Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis, in the Journal: (JOURNAL) of June/30,/2019
  • what: Instead, this study provides significant initial insights into the clinically meaningful and patient-centric endpoints of mortality and hospitalizations.
  • how: For a sensitivity analysis the authors used inverse probability treatment weighting (IPTW) instead of propensity score . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?